Search Results - "Uttenthal, Benjamin J."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Incidence and outcomes of post‐transplant lymphoproliferative disease after 5365 solid‐organ transplants over a 20‐year period at two UK transplant centres by Santarsieri, Anna, Rudge, John F., Amin, Irum, Gelson, Will, Parmar, Jasvir, Pettit, Stephen, Sharkey, Lisa, Uttenthal, Benjamin J., Follows, George A.

    Published in British journal of haematology (01-05-2022)
    “…Summary Post‐transplant lymphoproliferative disease (PTLD) is a life‐threatening complication of solid‐organ transplantation (SOT). We present the incidence…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Challenges in T cell receptor gene therapy by Uttenthal, Benjamin J., Chua, Ignatius, Morris, Emma C., Stauss, Hans J.

    Published in The journal of gene medicine (01-06-2012)
    “…The function of T lymphocytes as orchestrators and effectors of the adaptive immune response is directed by the specificity of their T cell receptors (TCRs)…”
    Get full text
    Journal Article
  6. 6

    The Wolf at the Door by Uttenthal, Benjamin J, Layton, D. Mark, Vyse, Timothy J, Schreiber, Benjamin E

    Published in The New England journal of medicine (07-06-2012)
    “…A 29-year-old man presented with a 1-week history of fever, night sweats, reduced appetite, and left upper abdominal pain exacerbated by inspiration. He…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Incidence and Outcomes of Post-Transplant Lymphoproliferative Disease after 5365 Solid Organ Transplants over a 20 Year Period at 2 UK Transplant Centres by Santarsieri, Anna, Butler, Andrew, Gelson, William, Pettit, Stephen, Rudge, John F, Torpey, Nicholas, Uttenthal, Benjamin J, Crawley, Charles, Follows, George A

    Published in Blood (23-11-2021)
    “…Background: Post-transplant lymphoproliferative disease (PTLD) confers a high morbidity and mortality in a vulnerable population. We present the epidemiology…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma by Bulley, Simon J, Lentell, Isabel C, O'Sullivan, Brendan, Follows, Annabel M, Sadullah, Shalal, Karanth, Mamatha, Young Min, Sandra, Russell, James, Uttenthal, Benjamin J, Follows, George A

    Published in Blood (08-12-2017)
    “…PEP-C (prednisolone, etoposide, procarbazine, and cyclophosphamide) is an orally administered chemotherapy regimen used with palliative intent in relapsed or…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Endogenous T Cell Receptors Drive Non-Specific Suppression by Foxp3 MHC Class I-Restricted T Cell Receptor-Transduced Polyclonal CD4+ T Cells in Models of Graft-Versus-Host Disease by Uttenthal, Benjamin J, Nicholson, Emma, Carpenter, Ben, Ghorashian, Sara, Wright, Graham P, Flutter, Barry R, Xue, Shao-An, Chakraverty, Ronjon, Morris, Emma

    Published in Blood (16-11-2012)
    “…Abstract 3152 Alloreactive immune responses directed against malignant cells in recipients of allogeneic hematopoietic stem cell transplants are able to cure…”
    Get full text
    Journal Article
  15. 15